Cargando…

Clinical and genetic characterization of hereditary breast cancer in a Chinese population

BACKGROUND: Breast cancer develops as a result of multiple gene mutations in combination with environmental risk factors. Causative variants in genes such as BRCA1 and/or BRCA2 have been shown to account for hereditary nature of certain breast cancers. However,other genes, such as ATM, PALB2, BRIP1,...

Descripción completa

Detalles Bibliográficos
Autores principales: Jian, Wenjing, Shao, Kang, Qin, Qi, Wang, Xiaohong, Song, Shufen, Wang, Xianming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663067/
https://www.ncbi.nlm.nih.gov/pubmed/29093764
http://dx.doi.org/10.1186/s13053-017-0079-4
_version_ 1783274757260574720
author Jian, Wenjing
Shao, Kang
Qin, Qi
Wang, Xiaohong
Song, Shufen
Wang, Xianming
author_facet Jian, Wenjing
Shao, Kang
Qin, Qi
Wang, Xiaohong
Song, Shufen
Wang, Xianming
author_sort Jian, Wenjing
collection PubMed
description BACKGROUND: Breast cancer develops as a result of multiple gene mutations in combination with environmental risk factors. Causative variants in genes such as BRCA1 and/or BRCA2 have been shown to account for hereditary nature of certain breast cancers. However,other genes, such as ATM, PALB2, BRIP1, CHEK, BARD1, while lower in frequency, may also increase breast cancer risk. There are few studies examining the role of these causative variants. Our study aimed to examine the clinical and genetic characterization of hereditary breast cancer in a Chinese population. METHODS: We tested a panel of 27 genes implicated in breast cancer risk in 240 participants using Next-Generation Sequencing. The prevalence of genetic causative variants was determined and the association between causative variants and clinico-pathological characteristics was analyzed. RESULTS: Causative variant rate was 19.2% in the breast cancer (case) group and 12.5% in the high-risk group. In the case group 2.5% of patients carried BRCA1 causative variant, 7.5% BRCA2 variants, 1.7% patients had MUTYH, CHEK or PALB2 variants, and 0.8% patients carried ATM, BARD1, NBN, RAD51C or TP53 variants. In the high-risk group 5.8% women carried MUTYH causative variants, 2.5% had causative variants in ATM, 1.7% patients had variants in BRCA2 and 0.8% in BARD1, BRIP1 or CDH1. There was no significant difference in the presence of causative variants among clinical stages of breast cancer, tumor size and lymph nodes status. However, eight of the 12 BRCA1/2 causative variants were found in the TNBC group. CONCLUSIONS: We found increased genetic causative variants in the familial breast cancer group and in high-risk women with a family history of breast cancer. However, the variant MUTYH c.892-2A > G may not be directly associated with hereditary breast carcinoma. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13053-017-0079-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5663067
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-56630672017-11-01 Clinical and genetic characterization of hereditary breast cancer in a Chinese population Jian, Wenjing Shao, Kang Qin, Qi Wang, Xiaohong Song, Shufen Wang, Xianming Hered Cancer Clin Pract Research BACKGROUND: Breast cancer develops as a result of multiple gene mutations in combination with environmental risk factors. Causative variants in genes such as BRCA1 and/or BRCA2 have been shown to account for hereditary nature of certain breast cancers. However,other genes, such as ATM, PALB2, BRIP1, CHEK, BARD1, while lower in frequency, may also increase breast cancer risk. There are few studies examining the role of these causative variants. Our study aimed to examine the clinical and genetic characterization of hereditary breast cancer in a Chinese population. METHODS: We tested a panel of 27 genes implicated in breast cancer risk in 240 participants using Next-Generation Sequencing. The prevalence of genetic causative variants was determined and the association between causative variants and clinico-pathological characteristics was analyzed. RESULTS: Causative variant rate was 19.2% in the breast cancer (case) group and 12.5% in the high-risk group. In the case group 2.5% of patients carried BRCA1 causative variant, 7.5% BRCA2 variants, 1.7% patients had MUTYH, CHEK or PALB2 variants, and 0.8% patients carried ATM, BARD1, NBN, RAD51C or TP53 variants. In the high-risk group 5.8% women carried MUTYH causative variants, 2.5% had causative variants in ATM, 1.7% patients had variants in BRCA2 and 0.8% in BARD1, BRIP1 or CDH1. There was no significant difference in the presence of causative variants among clinical stages of breast cancer, tumor size and lymph nodes status. However, eight of the 12 BRCA1/2 causative variants were found in the TNBC group. CONCLUSIONS: We found increased genetic causative variants in the familial breast cancer group and in high-risk women with a family history of breast cancer. However, the variant MUTYH c.892-2A > G may not be directly associated with hereditary breast carcinoma. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13053-017-0079-4) contains supplementary material, which is available to authorized users. BioMed Central 2017-10-30 /pmc/articles/PMC5663067/ /pubmed/29093764 http://dx.doi.org/10.1186/s13053-017-0079-4 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Jian, Wenjing
Shao, Kang
Qin, Qi
Wang, Xiaohong
Song, Shufen
Wang, Xianming
Clinical and genetic characterization of hereditary breast cancer in a Chinese population
title Clinical and genetic characterization of hereditary breast cancer in a Chinese population
title_full Clinical and genetic characterization of hereditary breast cancer in a Chinese population
title_fullStr Clinical and genetic characterization of hereditary breast cancer in a Chinese population
title_full_unstemmed Clinical and genetic characterization of hereditary breast cancer in a Chinese population
title_short Clinical and genetic characterization of hereditary breast cancer in a Chinese population
title_sort clinical and genetic characterization of hereditary breast cancer in a chinese population
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663067/
https://www.ncbi.nlm.nih.gov/pubmed/29093764
http://dx.doi.org/10.1186/s13053-017-0079-4
work_keys_str_mv AT jianwenjing clinicalandgeneticcharacterizationofhereditarybreastcancerinachinesepopulation
AT shaokang clinicalandgeneticcharacterizationofhereditarybreastcancerinachinesepopulation
AT qinqi clinicalandgeneticcharacterizationofhereditarybreastcancerinachinesepopulation
AT wangxiaohong clinicalandgeneticcharacterizationofhereditarybreastcancerinachinesepopulation
AT songshufen clinicalandgeneticcharacterizationofhereditarybreastcancerinachinesepopulation
AT wangxianming clinicalandgeneticcharacterizationofhereditarybreastcancerinachinesepopulation